These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 26922684)

  • 1. Antimicrobial resistance patterns of Pseudomonas aeruginosa in tertiary care hospitals of Makkah and Jeddah.
    Khan MA; Faiz A
    Ann Saudi Med; 2016; 36(1):23-8. PubMed ID: 26922684
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Goodlet KJ; Nicolau DP; Nailor MD
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance patterns of Pseudomonas aeruginosa to carbapenems and piperacillin/tazobactam.
    Mokaddas EM; Sanyal SC
    J Chemother; 1999 Apr; 11(2):93-6. PubMed ID: 10326738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial resistance among clinical isolates of Pseudomonas aeruginosa from patients in a teaching hospital, Riyadh, Saudi Arabia, 2001-2005.
    Babay HA
    Jpn J Infect Dis; 2007 May; 60(2-3):123-5. PubMed ID: 17515646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of combination therapy with cefepime, piperacillin-tazobactam, or meropenem with ciprofloxacin against multidrug-resistant Pseudomonas aeruginosa strains.
    Erdem I; Kucukercan M; Ceran N
    Chemotherapy; 2003 Dec; 49(6):294-7. PubMed ID: 14671429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillance Programme (2013-2015).
    Pfaller MA; Shortridge D; Sader HS; Castanheira M; Flamm RK
    Int J Antimicrob Agents; 2018 Feb; 51(2):181-189. PubMed ID: 28993143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of antimicrobial resistance among gram-negative isolates in an adult intensive care unit at a tertiary care center in Saudi Arabia.
    Al Johani SM; Akhter J; Balkhy H; El-Saed A; Younan M; Memish Z
    Ann Saudi Med; 2010; 30(5):364-9. PubMed ID: 20697174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipseudomonal activity of piperacillin/tazobactam: more than a decade of experience from the SENTRY Antimicrobial Surveillance Program (1997-2007).
    Jones RN; Stilwell MG; Rhomberg PR; Sader HS
    Diagn Microbiol Infect Dis; 2009 Nov; 65(3):331-4. PubMed ID: 19822273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital.
    Raja NS; Singh NN
    J Microbiol Immunol Infect; 2007 Feb; 40(1):45-9. PubMed ID: 17332906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial Susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa Isolates from United States Medical Centers Stratified by Infection Type: Results from the International Network for Optimal Resistance Monitoring (INFORM) Surveillance Program, 2015-2016.
    Sader HS; Castanheira M; Duncan LR; Flamm RK
    Diagn Microbiol Infect Dis; 2018 Sep; 92(1):69-74. PubMed ID: 29789189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
    Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y
    Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective evaluation of piperacillin-tazobactam, imipenem-cilastatin and meropenem used on surgical floors at a tertiary care hospital in Saudi Arabia.
    Youssif E; Aseeri M; Khoshhal S
    J Infect Public Health; 2018; 11(4):486-490. PubMed ID: 29153444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas aeruginosa: Evaluation of Pathogen Burden and Drug-Resistance Trends in a Tertiary Care Hospital.
    Saeed M; Rasheed F; Afzal RK; Hussain S; Riaz S; Ahmad A
    J Coll Physicians Surg Pak; 2018 Apr; 28(4):279-283. PubMed ID: 29615167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the use of broad-spectrum antibiotics after cefepime shortage: a time series analysis.
    Plüss-Suard C; Pannatier A; Ruffieux C; Kronenberg A; Mühlemann K; Zanetti G
    Antimicrob Agents Chemother; 2012 Feb; 56(2):989-94. PubMed ID: 22123703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation of the in-vitro effectiveness of ertapenem against Pseudomonas aeruginosa strains isolated from intensive care unit patients].
    Kiliç A; Küçükkaraaslan A; Senses Z; Baysallar M; Doğanci L
    Mikrobiyol Bul; 2004 Oct; 38(4):355-62. PubMed ID: 15700661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
    Dambrauskiene A; Adukauskiene D; Jeroch J; Vitkauskiene A
    Medicina (Kaunas); 2009; 45(1):1-7. PubMed ID: 19223699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12).
    Sader HS; Farrell DJ; Castanheira M; Flamm RK; Jones RN
    J Antimicrob Chemother; 2014 Oct; 69(10):2713-22. PubMed ID: 24917579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections.
    Van Eldere J
    J Antimicrob Chemother; 2003 Feb; 51(2):347-52. PubMed ID: 12562701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
    Kim HS; Park BK; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
    BMC Infect Dis; 2017 Jul; 17(1):500. PubMed ID: 28716109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.